- Home
- MRNA vs CSGP Comparison
MRNA vs CSGP Comparison
Compare MRNA & CSGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | CSGP |
|---|---|---|
| Founded | 2010 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 21.1B |
| IPO Year | 2018 | 1998 |
Fundamental Metrics
Financial Performance| Metric | MRNA | CSGP |
|---|---|---|
| Price | $48.69 | $36.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 14 |
| Target Price | $34.27 | ★ $67.00 |
| AVG Volume (30 Days) | 5.1M | ★ 5.4M |
| Earning Date | 05-01-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $19,263,000,000.00 | $965,230,000.00 |
| Revenue This Year | $9.36 | $19.71 |
| Revenue Next Year | $15.43 | $12.40 |
| P/E Ratio | ★ N/A | $1,815.50 |
| Revenue Growth | 4.29 | ★ 15.23 |
| 52 Week Low | $22.28 | $34.75 |
| 52 Week High | $59.55 | $97.43 |
Technical Indicators
Market Signals| Indicator | MRNA | CSGP |
|---|---|---|
| Relative Strength Index (RSI) | 41.15 | 32.74 |
| Support Level | $47.61 | $34.75 |
| Resistance Level | $54.94 | $69.64 |
| Average True Range (ATR) | 2.63 | 1.69 |
| MACD | -0.36 | 0.09 |
| Stochastic Oscillator | 1.70 | 24.84 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CSGP CoStar Group Inc.
CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors spanning office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many well-respected brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence into Canada, the United Kingdom, Spain, and France.